ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Virtus LifeSci Biotech Products ETF
103.46
-0.0139
-0.01%
盘后:
103.45
-0.0097
-0.01%
19:30 EDT
成交量:
8,264
成交额:
85.86万
市值:
1.14亿
市盈率:
- -
高:
104.51
开:
104.48
低:
103.45
收:
103.47
52周最高:
110.05
52周最低:
68.05
股本:
110.00万
流通股本:
110.00万
量比:
0.98
换手率:
0.75%
股息:
- -
股息率:
- -
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻
公告
概念
没有相关数据
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻
118款生物药专利悬崖将至,中国药企业迎战MNC最大专利悬崖
蓝鲸财经
·
09/10
复宏汉霖朱俊:未来所有制药企业都是AI制药企业,不存在不依赖AI的生物制药企业
睿见Economy
·
09/05
特朗普:8月就业数据超预期,要求美联储降息
特朗普社媒动态
·
09/04
康宁杰瑞生物制药回购56,000股 耗资492,430港元
财闻
·
09/04
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/BBP"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":103.4597,"timestamp":1789156800000,"preClose":103.4736,"halted":0,"volume":8264,"hourTrading":{"tag":"盘后","latestPrice":103.45,"preClose":103.4597,"latestTime":"19:30 EDT","volume":7,"amount":724.2785,"timestamp":1789169406685,"change":-0.0097,"changeRate":-0.000094,"amplitude":0},"delay":0,"changeRate":-0.00013433378175695717,"floatShares":1100004,"shares":1100004,"eps":0,"marketStatus":"休市中","change":-0.0139,"latestTime":"09-11 16:00:00 EDT","open":104.48,"high":104.51,"low":103.45,"amount":858590.9244799999,"amplitude":0.010244,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":103.4736,"sharesOutstanding":600004,"nav":103.503,"aum":113853473.24,"bidAskSpread":0.002245,"preHourTrading":{"tag":"盘前","latestPrice":103.4736,"preClose":103.4736,"latestTime":"07:00 EDT","volume":2,"amount":206.9472,"timestamp":1789124458151,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":103.45,"preClose":103.4597,"latestTime":"19:30 EDT","volume":7,"amount":724.2785,"timestamp":1789169406685,"change":-0.0097,"changeRate":-0.000094,"amplitude":0},"volumeRatio":0.9846065698607303,"impliedVol":0.2114,"impliedVolPercentile":0.2749},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1100004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9846065698607303,"shares":1100004,"dividePrice":0,"high":104.51,"amplitude":0.010244,"preClose":103.4736,"low":103.45,"week52Low":68.046,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":103.4597,"eps":0,"divideRate":0,"volume":8264,"delay":0,"ttmEps":0,"open":104.48,"prevYearClose":79.9149,"prevWeekClose":108.3272,"prevMonthClose":106.46,"prevQuarterClose":96.2686,"fiveDayClose":108.8566,"twentyDayClose":101.0899,"sixtyDayClose":87.5667},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666563124","title":"118款生物药专利悬崖将至,中国药企业迎战MNC最大专利悬崖","url":"https://stock-news.laohu8.com/highlight/detail?id=2666563124","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666563124?lang=zh_cn&edition=fundamental","pubTime":"2026-09-10 15:26","pubTimestamp":1789025185,"startTime":"0","endTime":"0","summary":"BCG合伙人杜菁博士指出,未来几年全球MNC将迎来史上最大专利悬崖,有118种生物制剂将会失去相应的专利保护,涉及2340亿美元市场。然而,目前这118款即将到期分子中,只有极少数在火热开发,大量缺口有待生物类似药填补。目前来说,创新药出海还没办法完成这个闭环,但生物类似药作为先头部队做出海试验,企业风险和获益会更高。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789025064363150858","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["FXH","MEDI","JDOC","PPH","IYH","TRUH","159839","RSPH","APXH","PJP","BBH","FHLC","TMED","BBP","GSKH","IHE","PBPH","BME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665936888","title":"复宏汉霖朱俊:未来所有制药企业都是AI制药企业,不存在不依赖AI的生物制药企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2665936888","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665936888?lang=zh_cn&edition=fundamental","pubTime":"2026-09-05 14:04","pubTimestamp":1788588240,"startTime":"0","endTime":"0","summary":"朱俊坦言,尽管近年来国家批准的创新药数量已领先全球,但临床疗效的提升依然艰难。他强调,如果AI不能进一步赋能,生物医药产业将继续处于原始状态。未来,所有的制药企业都必须是AI制药企业,不存在不依赖AI的生物制药企业。朱俊总认为,在全球变局下,只要企业能够用好AI、抓住精准人群并解决真实的临床痛点,即使十个机会中只能抓住一个,也足以支撑企业的长远发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2026-09-05/doc-iniquccs3668085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["QTOC","HK0000320264.USD","BK1191","VTHR","BK1161","01477","MRNX","ARTY","AIPO","BBP","HK0000306701.USD","03069","BK1574","HK0000306685.HKD","02696","HK0000320223.HKD","IBBQ","CHAT","MRNY","HK0000165453.HKD","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132454908","title":"特朗普:8月就业数据超预期,要求美联储降息","url":"https://stock-news.laohu8.com/highlight/detail?id=1132454908","media":"特朗普社媒动态","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132454908?lang=zh_cn&edition=fundamental","pubTime":"2026-09-04 21:41","pubTimestamp":1788529306,"startTime":"0","endTime":"0","summary":"","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FXR","DFUV",".DJI","LRCY",".SPX","PEVC","AVSD","UCC","IJK","VAW","CAOS","ANEW","KOMP","FXL","TSLP","BBP","CLIX","RJZ","CGDV",".IXIC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664337721","title":"康宁杰瑞生物制药回购56,000股 耗资492,430港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664337721","media":"财闻","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664337721?lang=zh_cn&edition=fundamental","pubTime":"2026-09-04 20:53","pubTimestamp":1788526380,"startTime":"0","endTime":"0","summary":"9月4日,康宁杰瑞生物制药于2026年9月4日在香港联交所回购56,000股普通股,每股回购价格最高HKD8.8、最低HKD8.75,付出价格总额HKD492,430。回购股份拟持作库存股份,拟注销数目为0。回购后,已发行股份数目由968,056,697股减至968,000,697股,库存股份数目由6,325,000股增至6,381,000股,已发行股份总数维持974,381,697股。此次回购依据2026年6月12日获通过的回购授权进行,该授权可回购股份总数为96,850,669股。回购后暂止期截至2026年10月4日。呈交者为执行董事徐霆。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-04/doc-iniqsrak4001786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CNAV","03069","BBP","EWH","MRNY","MRNX","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":10,"pageCount":1,"totalSize":39,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BBP\",params:#limit:6,delay:false,,,undefined,":[]}}